Effect of squalene on cyclophosphamide-induced toxicity

Clinica Chimica Acta

Volumn 364, Issue 1-2, 2006, Pages 335-342

  Senthilkumar, Subramanian ^a   Devaki, Thiruvengadam ^a   Manohar, Bhakthavatchalam Murali ^b   Babu, Munismay Suresh ^a  

^a UNIVERSITY OF MADRAS   (India)

^b MADRAS VETERINARY COLLEGE   (India)

Author keywords

Cardiotoxicity; Cyclophosphamide; Cytoprotectant; Hepatotoxicity; Nephrotoxicity; Squalene

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; CREATINE KINASE; CREATININE; CYCLOPHOSPHAMIDE; LACTATE DEHYDROGENASE; PROTEIN; SQUALENE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CARDIOTOXICITY; CELL PROTECTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DRUG ACTIVITY; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; UREA BLOOD LEVEL;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ASPARTATE AMINOTRANSFERASES; CHOLESTEROL; CREATINE KINASE; CYCLOPHOSPHAMIDE; HEART; INJECTIONS, INTRAPERITONEAL; KIDNEY; L-LACTATE DEHYDROGENASE; LIVER; MALE; MYOCARDIUM; RATS; RATS, WISTAR; SQUALENE; TRIGLYCERIDES;

ANIMALIA;

EID: 31044456008     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.07.032     Document Type: Article

References (58)

1. M.J. Ratain, and W. Plunkett Principles for chemotherapy, pharmacology J.F. Holland E.I. Frei Jr. R.C. Bast D.W. Kufe D.C. Morton R.R. Weiehselbaum Cancer medicine 1997 Williams and Wilkins Baltimore, MD 875 890
2. C. Dollery Cyclophosphamide C. Dollery Therapeutic drugs 1999 Churchill Livingstone Edinburg 349 353
3. M.A. Goldberg, J.H. Antin, E.C. Guinan, and J.M. Rappeport Cyclophosphamide cardiotoxicity: an analysis of doing as a risk factor Blood 68 1986 1114 1118
4. R. Bukowski The need for cytoprotection Eur J Cancer 32A 1999 S2 S4
5. L.H. Fraiser, S. Kanekel, and J.P. Kehrer Cyclophosphamide toxicity: characterizing and avoiding the problem Drugs 42 1991 781 795
6. N. Sladek Metabolism of cyclophosphamide by rat hepatic microsomes Cancer Res 1 1971 901 908
7. N.E. Sladek Metabolism of oxazaphosphorines Pharmacol Ther 37 1988 301 355
8. C. Shanholtz Acute life-threatening toxicity of cancer treatment Crit Care Clin 17 2001 483 502
9. B.A. Mills, and R.W. Roberts Cyclophosphamide-induced cardiomyopathy: a report of two cases and review of the English literature Cancer 43 1979 2223 2226
10. R. Rossi Nephrotoxicity of ifosfamide - moving towards understanding the molecular mechanisms Nephrol Dial Transplant 12 1997 1091 1092
11. R. Kleta, S. Fehring, R. Rossi, M. Mohrmann, and E. Schlatter Effects of ifosfamide and metabolites on membrane voltage (Vm) / conductance (gm) of LLCPK1 cells J Am Soc Nephrol 1996 1841 [abstract 7]
12. D.C. Sriover, S. Weisdorf, J. Bloomer, P. McGlave, and D. Weisdorf Nodular regenerative hyperplasia of the liver following bone marrow transplantation Hepatology 9 1989 443
13. K. Atkinson, J. Biggs, M. Ashby, A. Concannon, and A. Dodds Preparative regimens for marrow transplantation containing busulfan are associated with hemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis Bone Marrow Transplant 2 1987 385
14. H.M. Shulman, G.B. McDonald, and D. Matthews An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation Gastroenterology 79 1980 1178
15. S.M. Ludeman The chemistry of the metabolites of cyclophosphamide Curr Pharm Des 5 1999 627 643
16. J.C. Kern, and J.P. Kehrer Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis Chem Biol Interact 139 2002 79 95
17. M. Fouladi, D. Stempak, and J. Gammon Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin and etoposide chemotherapy in children with refractory carcinoma Cancer 92 2001 914 923
18. P.J. Shaw, and M. Blekley Systemic inflammatory response syndrome associated with amifostine Med Pediatr Oncol 34 2000 309 310
19. M.L. Henslay, L.M. Schuchter, and C. Lindley American Society of clinical oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants J Clin Oncol 17 1999 3333 3355
20. A.A. Qureshi, J.W. Lehmann, and D.M. Peterson Amaranth and its oil inhibit cholesterol biosynthesis in 6-week-old female chickens J Nutr 126 1996 1972 1978
21. T.F. Ko, T.M. Weng, and R.Y. Chiou Squalene content and antioxidant activity of Terminalia catappa leaves and seeds J Agric Food Chem 50 2002 5343 5348
22. S.P. Ivashkevich, L.I. Apukhorskaia, and V.P. Vendt Effects of sterols having different chemical structure and squalene on osmotic resistance of erythrocytes Biokhimiia 46 1981 1420 1425
23. D. Saint-Leger, A. Bague, E. Cohen, and M. Chivot A possible role for squalene in the pathogenesis of acne, I, in vitro study of squalene oxidation Br J Dermatol 114 1986 535 542
24. Y. Kohno, Y. Egawa, S. Itoh, S. Nagaoka, M. Takahashi, and K. Mukai Kinetic study of quenching reaction of singlet oxygen and scavenging reaction of free radical by squalene in n-butanol Biochim Biophys Acta 1256 1995 52 56
25. H.M. Storm, S.Y. Oh, B.F. Kimler, and S. Norton Radioprotection of mice by dietary squalene Lipids 28 1993 555 559
26. S. Fan, I. Ho, F.L. Yeoh, C. Lin, and T. Lee Squalene inhibits sodium arsenite-induced sister chromatid exchanges and micronuclei in Chinese hamster ovary-K1 cells Mutat Res 368 1996 165 169
27. H. Kamimara, N. Koga, K. Oguri, and H. Yoshimura Enhanced elimination of theophylline, phenobarbital and strychnine from the bodies of rats and mice by squalene treatment J Pharmacobiodyn 15 1992 215 221
28. E. Richter, and S.G. Schafer Effect of squalene on hexachlorobenzene (HCB) concentrations in tissues of mice J Environ Sci Health B 17 1982 195 203
29. C.V. Rao, H.L. Newmark, and B.S. Reddy Chemopreventive effect of squalene on colon cancer Carcinogenesis 19 1998 287 290
30. T.J. Smith, G.Y. Yang, D.N. Seril, J. Liao, and S. Kim Inhibition of 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis by dietary olive oil and squalene Carcinogenesis 19 1998 703 706
31. Y. Tomita Immunological role of vitamin A and its related substances in prevention of cancer Nutr Cancer 5 1983 187 194
32. T.E. Strandberg, R.S. Tilvis, and T.A. Miettinen Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment J Lipid Res 31 1990 1637 1643
33. T.A. Miettinen, and H. Vanhanen Serum concentration and metabolism of cholesterol during rapeseed oil and squalene feeding Am J Clin Nutr 59 1994 356 363
34. H. Gylling, and T.A. Miettinen Post absorptive metabolism of dietary squalene Atherosclerosis 106 1994 169 178
35. S. Okinaka, H. Sugita, and T. Mamoi Cysteine-stimulated serum creatine kinase in health and disease J Lab Clin Med 64 1964 299 305
36. J. King The dehydrogenases or oxidoreductases-lactacte dehydrogenase D. Van Practical clinical enzymology 1965 Nostrand Company Limited London 83 93
37. J. King The transferases-alanine and aspartate transaminases D. Van Practical clinical enzymology 1965 Nostrand Company Limited London 121 138
38. J. King The hydrolases - acid and alkaline phosphatases D. Van Practical clinical enzymology 1965 Nostrand Company Limited London 199 208
39. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J Biol Chem 193 1951 265 275
40. S. Natelson, M.L. Scott, and D. Beffa A rapid method for the estimation of urea in biological fluids by means of the reaction between diacetyl monoxime and urea Am J Chem Pathol 21 1951 275 281
41. J. Broad, and J.H. Sirota Renal clearance of endogenous creatinine in man J Clin Invest 27 1948 645
42. A.C. Parekh, and D.H. Jung Cholesterol determination with ferric acetate-uranyl acetate and sulphuric acid-ferrous sulphate reagents Anal Chem 42 1970 1423 1427
43. C.B. Foster, and R.T. Dunn Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method Clin Chem 196 1973 338 340
44. H.T. Malloy, and K.A. Evelyn The determination of bilirubin with the photometric colorimeter J Biol Chem 119 1937 481 490
45. M.H. Ross, E.J. Reith, and L.J. Romrell Histology A text an atlas (ki sp k) 1989 Williams & Wilkins Baltimore, Maryland 1 2
46. B. Halliwell, and J.M.C. Gutteridge Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy Lancet 1 1984 1396 1397
47. M.I. Gharib, and A.K. Burnett Chemotherapy induced cardiotoxicity: current practice and prospects of prophylaxis Eur J Heart Fail 4 2002 235 242
48. T.X. O'Connel, and M.C. Benenbaum Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide Cancer Res 34 1974 1586 1591
49. L.K. Lee, G.S. Harman, R.J. Hohl, and R.D. Gingrieh Fatal cyclophosphamide cardiomyopathy: its clinical course and treatment Bone Marrow Transplant 18 1996 573 577
50. Hearse DJ. Cellular damage during myocardial ischaemia: metabolic changes leading to enzyme leakage. In: Hearse DJ, Leiris J, Loisance D, editors. Enzymes in cadiology. New York: John Wiley and Sons Limited. p. 1-21.
51. H.A. Hopkins, W.L. Betsill, A.S. Hobson, and W.B. Looney Cyclophosphamide-induced cardiomyopathy in the rat Cancer Treat Rep 66 1982 1521 1527
52. F.R. Appelbaum, J.A. Strauchen, and R.G. Graw Jr. Acute lethal carditis caused by high-dose combination chemotherapy, A unique clinical and pathological entity Lancet 1 1976 58 62
53. K.H. Sabeena Farvin, R. Anandan, S. Hari Senthil Kumar, K.S. Shiny, T.V. Sankar, and T.K. Thankappan Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats Pharm Res 50 2004 231 236
54. B.R. McDonald, S. Kirmani, M. Vasquez, and R.L. Mehta Acute renal failure associated with the use of intraperitoneal carboplatin: a report of two cases and review of the literature Am J Med 90 1991 386 391
55. S.I. Bearman, F.R. Appelbaum, and C.D. Buckner Regimen-related toxicity in patients undergoing bone marrow transplantation J Clin Oncol 6 1988 1562
56. K. Cagler, C. Kinalp, and F. Arpaci Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation Nephrol Dial Transplant 17 2002 1931 1935
57. Rosen HR, Keeffe EB. Laboratory evaluation of the patient with signs and symptoms of liver disease. In: Brandt LJ, editor. Clinical practice of gasteroenterology. Philadelphia: Churchil Livinstone. p. 812-20.
58. T.E. Strandberg, R.S. Tilvis, and T.A. Miettinen Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment J Lipid Res 31 1990 1637 1643